gMG clinical trials at UCSF

1 research study open to eligible people

gMG is a disease that makes muscles weak. UCSF is studying how a drug called Ravulizumab works in children with gMG. The study looks at how safe the drug is and how it affects the body.

Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
open to all eligible people
The primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG.
San Francisco, California and other locations

Last updated: September 23, 2024

gMG clinical trials at UCSF

Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)